Kamal Adawi insider trades

Open-market stock purchases and sales by Kamal Adawi, Chief Financial Officer at Fate Therapeutics Inc, from SEC Form 4 filings since Sep 18, 2019.

Recent trades

DateStockTradeValue
Jan 15, 2026FATE Fate Therapeutics IncBought (not open market)—
Jan 15, 2026FATE Fate Therapeutics IncBought (not open market)—
Oct 20, 2025FATE Fate Therapeutics IncBought (not open market)—
Oct 20, 2025FATE Fate Therapeutics IncBought (not open market)—

Companies traded

  • FATE Fate Therapeutics Inc: other filings, last Jan 15, 2026
  • XGN Exagen Inc: 5 sales, last Mar 4, 2024

Get free alerts when Kamal Adawi files a new trade →